# Destiny Pharma Limited (03167025)

> Why UK company 03167025 went into administration, from the administrators' statement filed at Companies House, by companydig. Interactive version: https://companydig.co.uk/company/03167025

- **Status:** Administration ended
- **Administration began:** 2024-08-21
- **Administrators' firm:** Cork Gully
- **Formerly:** Destiny Pharma PLC; Destiny Pharma Limited; Destiny Pharma Holdings Limited; Destiny Pharma Limited; Destiny Consultants Limited
- **Incorporated:** 1996-03-04
- **Location:** London
- **Industry:** 72190 Other research and experimental development on natural sciences and engineering

## Why it went into administration

- Cash flow / liquidity pressure

## From the administrators' statement

Creditors should note that, unless otherwise stated, this section of the proposals has been prepared based on information provided by the Board and from the books and records of the Company, as opposed to the personal knowledge of the Joint Administrators.

The Company was incorporated on 4 March 1996 and was admitted to trading on the AIM Market of the London Stock Exchange (“AIM”) in 2017.

The Company operates in the drug development sector, trading from Sussex Innovation Centre in Brighton since incorporation. At the date of Administration, the Company employed 14 full-time employees led by a management team with extensive experience in fundraising, licensing deals and developing and commercialising innovative new medicines.

Statement of proposals: https://find-and-update.company-information.service.gov.uk/company/03167025/filing-history/MzQzOTE4NDQ3MWFkaXF6a2N4/document?format=pdf&download=0
Companies House register: https://find-and-update.company-information.service.gov.uk/company/03167025

Contains public sector information from Companies House, licensed under the Open Government Licence v3.0.